ctrl K

Advertisement

BioPlus Acquisition Corp. (BIOSU)

NASDAQ: BIOSU · Real-Time Price · USD

10.80

-0.04 (-0.37%)

At close: Oct 06, 2023, 7:59 PM

BioPlus Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	708.9M	817.2M	935.6M
Cost of Revenue	1.17M	n/a	465.9M	547.9M	670M
Gross Profit	-1.17M	n/a	243M	269.3M	265.6M
Operating Income	-1.17M	-162.43	-108.5M	-52.7M	-77.7M
Interest Income	3.17M	9.49	n/a	n/a	n/a
Pretax Income	2M	-152.94	-51M	-67.4M	-32.4M
Net Income	5.16M	-152.94	-51.6M	-131M	-34.4M
Selling & General & Admin	1.17K	162.43	47.3M	63.3M	66M
Research & Development	n/a	n/a	n/a	n/a	n/a
Other Expenses	1.17M	n/a	189.6M	220.8M	197.7M
Operating Expenses	1.17M	162.43	236.9M	284.1M	263.7M
Interest Expense	n/a	n/a	-57.4M	-52.1M	-38.2M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.17M	162.43	702.8M	832M	933.7M
Income Tax Expense	-3.17M	9.49	600K	63.6M	2M
Shares Outstanding (Basic)	597.79M	6.88K	127.9M	123.8M	93.7M
Shares Outstanding (Diluted)	597.79M	6.88K	127.9M	123.8M	93.7M
EPS (Basic)	0.01	-0.02	-0.4	-1.06	-0.37
EPS (Diluted)	0.01	-0.02	-0.4	-1.06	-0.37
EBITDA	-1.17M	9.49	-84.9M	-24.97M	-56.15M
EBIT	n/a	n/a	-108.4M	-119.5M	-70.6M
Depreciation & Amortization	228.49K	236.56K	23.6M	27.73M	21.55M